Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
18.90
+0.27 (1.45%)
At close: Oct 22, 2026, 4:00 PM EDT
18.74
-0.16 (-0.87%)
After-hours: Oct 22, 2026, 5:33 PM EDT
Legend Biotech Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $65 | Buy | Reiterates | $65 | +243.92% | Oct 19, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $39 → $38 | Buy | Maintains | $39 → $38 | +101.53% | Oct 14, 2026 |
| Barclays | Barclays | Buy Maintains $74 → $68 | Buy | Maintains | $74 → $68 | +259.79% | Oct 13, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains $35 → $33 | Hold | Maintains | $35 → $33 | +74.60% | Oct 9, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $58 → $56 | Buy | Maintains | $58 → $56 | +196.30% | Oct 8, 2026 |
| UBS | UBS | Hold Reiterates $28 → $24 | Hold | Reiterates | $28 → $24 | +26.98% | Oct 2, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $49 → $48 | Buy | Maintains | $49 → $48 | +153.97% | Aug 12, 2026 |
| Oppenheimer | Oppenheimer | Hold Downgrades $75 → $40 | Hold | Downgrades | $75 → $40 | +111.64% | Aug 12, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.